STOCK TITAN

Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Johnson & Johnson (NYSE: JNJ) will host a conference call on April 18, 2023, at 8:30 a.m. (Eastern Time) to discuss its first-quarter results. Key executives, including Joseph J. Wolk and Jessica Moore, will lead the call, which will also include a Q&A session. Investors can join via webcast at www.investor.jnj.com or by dialing specific numbers for U.S. and international participants. A replay will be available until May 3, 2023. The press release with detailed financial results will be published at approximately 6:45 a.m. (Eastern Time) on the same day.

Positive
  • Scheduled conference call will provide first-quarter results, potentially impacting investor confidence.
  • Replay of the call ensures wider accessibility for investors.
Negative
  • None.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 18th to review first-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson’s executive team.

Investors and other interested parties can access the webcast/conference call in the following ways:

  • The webcast and presentation material are accessible at Johnson & Johnson’s website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
  • By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
  • A replay of the conference call will be available until approximately 12:00 a.m. on May 3rd. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13736719.
  • The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.
  • Please refer to www.investor.jnj.com for a complete list of currently planned earnings webcast/conference calls. Please note the second-quarter date of Thursday, July 20th, 2023.

About Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest, most diversified healthcare products company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

Investor Contact:

RA-JJCUS-InvestorRel@ITS.JNJ.com

Media Contact:

media-relations@its.jnj.com

Source: Johnson & Johnson

FAQ

What is the date of the Johnson & Johnson conference call regarding first-quarter results?

The conference call is scheduled for April 18, 2023.

What time will the Johnson & Johnson earnings call start?

The earnings call will start at 8:30 a.m. Eastern Time.

How can I access the Johnson & Johnson earnings call?

You can access the call via webcast at www.investor.jnj.com or by dialing specific participant numbers.

When will the Johnson & Johnson press release be available?

The press release will be available at approximately 6:45 a.m. Eastern Time on April 18, 2023.

When is the replay available for the Johnson & Johnson conference call?

The replay will be available until approximately 12:00 a.m. on May 3, 2023.

Johnson & Johnson

NYSE:JNJ

JNJ Rankings

JNJ Latest News

JNJ Stock Data

351.90B
2.41B
0.09%
73.15%
0.73%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NEW BRUNSWICK